Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02663635 · ClinicalTrials.gov registry record · Phase 3
Simulated Clinical Use Testing on Safe'N'Sound 1ML Stalked Passive Delivery System With Add-On Extended Finger Flanges
A Phase 3 study of Needle Stick, sponsored by Nemera La Verpilliere.
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT02663635: Completed Phase 3 study of Needle Stick, sponsored by Nemera La Verpilliere.
NCT02663635 is a Phase 3 study of Needle Stick that has completed, run by Nemera La Verpilliere. The registered enrollment target is 30 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02663635, a Phase 3 study of Needle Stick, has completed, sponsored by Nemera La Verpilliere.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
A simulated clinical use testing the Save'N'Sound 1mL staked Passive Delivery System with add-on extended finger flanges
Conditions Studied
Interventions
- DEVICE Safe'N'Sound
Study Locations (1)
Minnesota
- NAMSA - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-01 |
| Phase | Phase 3 |
What the finished NCT02663635 record still lists
NCT02663635 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Needle Stick appearing as the primary indexed condition, and to 1 intervention - of which Safe'N'Sound is the first listed.
NCT02663635 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02663635 about?
NCT02663635 is a clinical study titled "Simulated Clinical Use Testing on Safe'N'Sound 1ML Stalked Passive Delivery System With Add-On Extended Finger Flanges". A simulated clinical use testing the Save'N'Sound 1mL staked Passive Delivery System with add-on extended finger flanges
What is the current status of trial NCT02663635?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2016-01. Estimated completion is 2016-01.
What conditions does trial NCT02663635 study?
This clinical trial studies the following conditions: Needle Stick.
What interventions are being tested in trial NCT02663635?
The interventions under investigation include: Safe'N'Sound (DEVICE).
Who is sponsoring clinical trial NCT02663635?
This trial is sponsored by Nemera La Verpilliere, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02663635 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Needle Stick
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02663635's enrollment target sits among peer trials
30 1917th of 2000 higher than 68 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia